Rivulet Entertainment (RIVF) 10-Q 14 Nov 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 07, 2022
Details
Registrant CIK	0001342936
Fiscal Year End	--12-31
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	000-52390
Entity Registrant Name	Advanced Voice Recognition Systems, Inc.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	98-0511932
Entity Address, Address Line One	7659 E. Wood Drive
Entity Address, City or Town	Scottsdale
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85260
City Area Code	(480)
Local Phone Number	704-4183
Title of 12(b) Security	Common Stock par value $0.001 per share
Trading Symbol	AVOI
Security Exchange Name	NONE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		284,920,269
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited)) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current Assets
Cash and cash equivalents	$ 152	$ 12,148
Total Current Assets	152	12,148
Non-Current Assets
Patent, net	0	0
Total Non-Current Assets	0	0
Total Assets	152	12,148
Current Liabilities
Accounts payable	103,992	101,182
Payroll	162,381	162,380
Note Payable AIP	19,935	19,935
Advance Related Party	33,493	14,700
Accrued Interest	15.450	13,955
Total Current Liabilities	335,251	312,152
Total Liabilities	335,251	312,152
Stockholders' Deficit
Common stock	284,920	284,587
Additional paid-in capital	8,003,500	7,998,833
Accumulated Deficit	(8,623,519)	(8,583,424)
Total Stockholders' Deficit	(335,099)	(300,004)
Total Liabilities and Stockholders' Deficit	$ 152	$ 12,148

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited)) - Parenthetical - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Details
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	547,500,000	547,500,000
Common Stock, Shares, Issued	284,920,269	284,920,269
Common Stock, Shares, Outstanding	284,586,935	284,586,935

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Details
Sales	$ 0	$ 0	$ 0	$ 0
Cost of goods sold	0	0	0	0
Gross profit	0	0	0	0
Operating expenses
Compensation	25	25	4,071	117
Professional fees	6,726	8,900	26,397	32,565
Office	2,447	5,997	6,463	17,452
Other	357	482	1,346	1,471
Total operating expenses	9,555	15,404	38,277	51,605
Loss from operations	(9,555)	(15,404)	(38,277)	(51,605)
Other income and (expense)
Interest expense	(579)	(594)	(1,818)	(1,741)
Net other expense	(579)	(594)	(1,818)	(1,741)
Loss before income taxes	(10,134)	(15,998)	(40,095)	(53,346)
Provision for income taxes	0	0	0	0
Net Loss	$ (10,134)	$ (15,998)	$ (40,095)	$ (53,346)
Basic and diluted loss per common share	$ 0	$ 0	$ 0	$ 0
Weighted average number of common shares	284,920,269	280,506,935	284,920,269	280,446,935

Condensed Statement of Stockhol

Condensed Statement of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2020	$ 280,387	$ 7,957,033	$ (8,500,043)	$ (262,623)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	280,386,935
Stock Issued During Period, Value, Purchase of Assets	$ 0	0	0	0
Stock Issued During Period, Shares, Purchase of Assets	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(18,900)	(18,900)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2021	$ 280,387	7,957,033	(8,518,943)	(281,523)
Shares, Outstanding, Ending Balance at Mar. 31, 2021	280,386,935
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2020	$ 280,387	7,957,033	(8,500,043)	(262,623)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020	280,386,935
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest				(53,346)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2021	$ 280,587	7,958,833	(8,537,391)	(297,971)
Shares, Outstanding, Ending Balance at Sep. 30, 2021	280,586,935
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2021	$ 280,387	7,957,033	(8,518,943)	(281,523)
Shares, Outstanding, Beginning Balance at Mar. 31, 2021	280,386,935
Stock Issued During Period, Value, Purchase of Assets	$ 200	1,800	0	2,000
Stock Issued During Period, Shares, Purchase of Assets	200,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(18,448)	(18,448)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2021	$ 282,587	7,973,833	(8,553,389)	(269,969)
Shares, Outstanding, Ending Balance at Jun. 30, 2021	282,586,935
Stock Issued During Period, Value, Purchase of Assets	$ 2,000	15,000	0	17,000
Stock Issued During Period, Shares, Purchase of Assets	2,000,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(15,998)	(15,998)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2021	$ 280,587	7,958,833	(8,537,391)	(297,971)
Shares, Outstanding, Ending Balance at Sep. 30, 2021	280,586,935
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2021	$ 284,587	7,998,833	(8,583,424)	(300,004)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	284,586,935
Stock Issued During Period, Value, Purchase of Assets	$ 333	4,667	0	5,000
Stock Issued During Period, Shares, Purchase of Assets	333,334
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(20,183)	(20,183)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2022	$ 284,920	8,003,500	(8,603,607)	(315,187)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	284,920,269
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2021	$ 284,587	7,998,833	(8,583,424)	(300,004)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	284,586,935
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest				(40,095)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2022	$ 284,920	8,003,500	(8,623,519)	(335,099)
Shares, Outstanding, Ending Balance at Sep. 30, 2022	284,920,269
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2022	$ 284,920	8,003,500	(8,603,607)	(315,187)
Shares, Outstanding, Beginning Balance at Mar. 31, 2022	284,920,269
Stock Issued During Period, Value, Purchase of Assets	$ 0	0	0	0
Stock Issued During Period, Shares, Purchase of Assets	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(9,778)	(9,778)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2022	$ 284,920	8,003,500	(8,613,385)	(324,965)
Shares, Outstanding, Ending Balance at Jun. 30, 2022	284,920,269
Stock Issued During Period, Value, Purchase of Assets	$ 0	0	0	0
Stock Issued During Period, Shares, Purchase of Assets	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(10,134)	(10,134)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2022	$ 284,920	$ 8,003,500	$ (8,623,519)	$ (335,099)
Shares, Outstanding, Ending Balance at Sep. 30, 2022	284,920,269

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net loss	$ (40,095)	$ (53,346)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization and depreciation	0	11,028
Changes in operating liabilities
Accounts payable and accrued liabilities	4,306	14,211
Net cash used in operating activities	(35,789)	(28,107)
Cash Flows from Investing Activities
Payments for deferred costs	0	0
Net cash used in investing activities	0	0
Cash Flows from Financing Activities
Proceeds from sale of common stock	5,000	19,000
Advance from related party	18,793	13,990
Net cash provided by financing activities	23,793	32,990
Net change in cash	(11,996)	4,883
Cash and cash equivalents	12,148	348
Cash and cash equivalents	152	5,231
Supplemental Disclosure of Cash Flow Information
Interest	1,495	1,495
Income taxes	$ 0	$ 0

Note 1. Nature of Operations

Note 1. Nature of Operations	9 Months Ended
	Sep. 30, 2022
Notes
Note 1. Nature of Operations	Note 1. Nature of Operations Company Overview The operations of Advanced Voice Recognition Systems, Inc. (“AVRS” or the “Company”), http://www.avrsys.com, commenced in 1994 with a predecessor entity called NCC, Inc. NCC, Inc. was incorporated on March 15, 1994 in the State of Ohio. NCC, Inc. operated as a software and hardware development company that marketed voice recognition and transcription products for commercial applications. In May 2000, WG Investments, LLC acquired the assets of NCC, Inc. and subsequently changed its name to NCC, LLC. NCC, LLC (also a predecessor to AVRS) continued the operations of NCC, Inc. until approximately December 31, 2001, when shifts in the industry’s markets caused NCC, LLC to suspend its operations. AVRS was incorporated in the State of Colorado on July 7, 2005. In September 2005, the members of NCC, LLC transferred all of their membership interests in NCC, LLC to AVRS in exchange for 93,333,333 shares (post-recapitalization) of AVRS common stock. In December 2005, the Board of Directors approved a 1.5-to-1 stock split issuing 46,666,667 common shares (post-recapitalization), which increased the number of common shares outstanding to 140 million shares (post-capitalization). Following the incorporation of AVRS, the Company initiated a new business plan and intends to continue its operations in the voice recognition and transcription industry. AVRS is a software development company specializing in speech recognition technologies. AVRS has successfully obtained patent protection of its proprietary technology (refer to Note 3, Intangible Assets). The Company continues to explore all options to monetize and enforce our patent portfolio through patent enforcement and licensing of the six patents issued. Stock Purchase Agreements During the nine months ended September 30, 2022, the Company entered into a Stock Purchase Agreement for the private sale to one person or entity of an aggregate of 333,334 shares of the common stock for aggregate proceeds of $5,000. Full payment was received in the period. During the year ended December 31, 2021 the Company entered into Stock Purchase Agreements for the private sale to five persons or entities of an aggregate of 4,200,000 shares of the common stock for aggregate proceeds of $46,000, full payment of which was received in the period. Commitments and Contingencies On April 20, 2015 Advanced Voice Recognition Systems, Inc. (“AVRS”) entered into a Material Letter Agreement with an unrelated third party (“AIP”) in which they promise to pay to patent legal counsel funds to continue prosecuting Patents on behalf of AVRS. AVRS promises to pay AIP, or to such other holder of this promissory note (Note) as designate, the principal, together with a premium of ten percent (10%) of Principle and two percent (2%) of proceeds received by Company from a Monetization Event initiated by AIP. Interest was accrued and reported at September 30, 2022. On November 1, 2016, Advanced Voice Recognition Systems, Inc. (“ AVRS Agreement Patent Rights On June 21, 2018, Advanced Voice Recognition Systems, Inc. (“ AVRS Agreement the Firm On July 22, 2019 Apple, Inc. submitted a petition for Inter Partes Review (IPR) of the AVRS patent. It was ordered in the case of AVRS, Inc. v. Apple Inc (Case No. 2-18-cv-2083) that the parties’ stipulation was granted and the case is stayed pending the resolution of the IPR proceeding. Buether Joe and Carpenter, LLC (BJC), our representation in the AVRS v. Apple litigation represents AVRS in the IPR. The IPR response to the Patent Trial and Appeal Board (PTAB) was done November 8, 2019. On January 13, 2021, the United States Patent and Trademark Office Patent Trial and Appeal Board (PTAB) issued a Final Written Decision under 35 U.S.C. § 318(a) in Inter Partes Review

Note 2. Significant Accounting

Note 2. Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Notes
Note 2. Significant Accounting Policies	Note 2. Significant Accounting Policies Unaudited Financial Information The accompanying financial information at September 30, 2022 and for the nine months ended September 30, 2022 and 2021 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company’s financial position at September 30, 2022 and its operating results for the nine months ended September 30, 2022 and 2021 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) for the year ended December 31, 2021. The results of operations for the nine months ended September 30, 2022 are not necessarily an indication of operating results to be expected for the year ending December 31, 2022. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Liabilities exceed assets and there is a capital deficiency of $335,099 and no significant revenues. The Company may be unable to continue as a going concern for a reasonable period of time. The financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis and ultimately to attain profitability. During the twelve months ended December 31, 2021 the Company received an aggregate of $46,000 from the sale of shares in private offerings of its common stock. During the nine months ended September 30, 2022, the Company received an aggregate of $5,000 from the sale of shares in private offerings of its common stock. The Company’s current operations are related to patent monetization and filing of additional patents. The Company has entered into a letter agreement with Dominion Harbor Group, LLC to provide strategic advisory services to AVRS. Dominion has agreed to advanced costs up to an aggregate of $10,000,000. On June 28, 2017 the Company and Dominion agreed to terminate the August 20, 2015 Letter Agreement. The Company did not incur any material early termination penalties. In addition, the Company has revised the Contingent Fee Agreement with Buether Joe & Carpenter, LLC which will represent AVRS in connection with investigating and asserting claims to the AVRS patents including licensing and litigation activities. Any and all advanced costs will only become liabilities if successful. On June 6, 2017 AVRS and BJC revised the Contingent Fee Agreement as it related to the termination of the August 20, 2015 Dominion Harbor Letter Agreement. There is no guarantee that AVRS will be able to provide the capital required for the Company to continue as a going concern. Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents. The Company had cash at September 30, 2022 of $152, and $12,148 at December 31, 2021. No amounts resulted from cash equivalents.

Note 3. Intangible and Fixed As

Note 3. Intangible and Fixed Assets	9 Months Ended
	Sep. 30, 2022
Notes
Note 3. Intangible and Fixed Assets	Note 3. Intangible and Fixed Assets Intangible Assets The Company monitors the anticipated outcome of legal actions, and if it determines that the success of the defense of a patent is probable, and so long as the Company believes that the future economic benefit of the patent will be increased, the Company capitalizes external legal costs incurred in the defense of the patent. Upon successful defense of litigation, the amounts previously capitalized are amortized over the remaining life of the patent. On July 7, 2009, U.S. Patent # 7,558,730, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning on July 7, 2009 and ending 20 years from the application date of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2009 and the Company began amortization. AVRS filed a Complaint in the United States District Court Northern District for Arizona (Case No. 2-18-cv-2083) on July 3, 2018, and alleges that Apple products infringe U.S. Patent No. 7,558,730 entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols” (the “‘730 Patent”). The patent was fully amortized in the fourth quarter 2021. On May 24, 2011, U.S. Patent #7,949,534, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning May 24, 2011 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended June 30, 2011 and the Company began amortization. The patent was fully amortized in the fourth quarter 2021. On March 6, 2012, U.S. Patent #8,131,557, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning March 6, 2012 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended March 31, 2012 and the Company began amortization. The patent was fully amortized in the fourth quarter 2021. On July 30, 2013, U.S. Patent #8,498,871, entitled “Dynamic Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning on July 30, 2013 and ending 20 years from the application date of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2013 and the Company began amortization. The patent was fully amortized in the fourth quarter 2021. On September 22, 2015, U.S. Patent #9,142,217, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning September 22, 2015 and ending 20 years from the application date of the parent application (US Patent No. 7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2015 and the Company began amortization. The patent was fully amortized in the fourth quarter 2021. On April 3, 2018, U.S. Patent #9,934,786, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning April 3, 2018 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001 or November 27, 2021. The deferred costs were capitalized during the quarter ended June 30, 2018 and the Company began amortization. The patent was fully amortized in the fourth quarter 2021.

Note 4. Related Party Transacti

Note 4. Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Notes
Note 4. Related Party Transactions	Note 4. Related Party Transactions Related Parties Transactions and Indebtedness The Company owed the officers aggregate of $162,381 at September 30, 2022 and $ 162,380 December 31, 2021 for accrued payroll. During the period of nine months ending September 30, 2022, September 30, 2021 the Company paid gross payroll of $4,071 and $117 for payroll expenses. At September 30, 2022 the Secretary Treasurer advanced the Company $33,493 for operating expenses. At September 30, 2021 our Secretary Treasurer advanced the Company $14,700 for operating expenses.

Note 5. Note Payable & Accounts

Note 5. Note Payable & Accounts Payable	9 Months Ended
	Sep. 30, 2022
Notes
Note 5. Note Payable & Accounts Payable	Note 5. Note Payable & Accounts Payable On April 20, 2015, the Company entered into a Material Letter Agreement with an unrelated third-party AIP” in which they promise to pay to patent legal counsel funds to continue prosecuting Patents on behalf of AVRS. AVRS promises to pay AIP, or to such other holder of this promissory note (Note) as designate, the principal, together with a premium of ten percent (10%) of Principle and two percent (2%) of proceeds received by Company from a Monetization Event initiated by AIP. Interest was accrued and reported at September 30, 2022. On September 24, 2018, the Company, entered into Promissory Note with Walter Geldenhuys, who is our President, Chief Executive Officer and Chief Financial Officer, and who serves as a member of our Board of Directors. The Promissory Note is effective as of September 24, 2018 in the principal amount of $9,000 with a maturity date of the Promissory Note September 24, 2019. Interest at 4% per annum was charged and accrued at December 31, 2018. The Company repaid $2,500 of the note on December 10, 2018. During 2019 the Company repaid $6,500, paying the note in full on December 27, 2019. Interest at 4% per annum was charged and accrued at December 31, 2019. Accrued interest of $254 was paid on February 28, 2020.

Note 6. Stockholder Equity _ (D

Note 6. Stockholder Equity / (Deficit)	9 Months Ended
	Sep. 30, 2022
Notes
Note 6. Stockholder Equity / (Deficit)	Note 6. Stockholder Equity / (Deficit) The Company has issued shares of its common stock pursuant to certain agreements as described in Note 1.

Note 7. Subsequent Events

Note 7. Subsequent Events	9 Months Ended
	Sep. 30, 2022
Notes
Note 7. Subsequent Events	Note 7. Subsequent Events None

Note 2. Significant Accountin_2

Note 2. Significant Accounting Policies: Unaudited Financial Information (Policies)	9 Months Ended
	Sep. 30, 2022
Policies
Unaudited Financial Information	Unaudited Financial Information The accompanying financial information at September 30, 2022 and for the nine months ended September 30, 2022 and 2021 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company’s financial position at September 30, 2022 and its operating results for the nine months ended September 30, 2022 and 2021 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) for the year ended December 31, 2021. The results of operations for the nine months ended September 30, 2022 are not necessarily an indication of operating results to be expected for the year ending December 31, 2022.

Note 2. Significant Accountin_3

Note 2. Significant Accounting Policies: Going Concern (Policies)	9 Months Ended
	Sep. 30, 2022
Policies
Going Concern	Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Liabilities exceed assets and there is a capital deficiency of $335,099 and no significant revenues. The Company may be unable to continue as a going concern for a reasonable period of time. The financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis and ultimately to attain profitability. During the twelve months ended December 31, 2021 the Company received an aggregate of $46,000 from the sale of shares in private offerings of its common stock. During the nine months ended September 30, 2022, the Company received an aggregate of $5,000 from the sale of shares in private offerings of its common stock. The Company’s current operations are related to patent monetization and filing of additional patents. The Company has entered into a letter agreement with Dominion Harbor Group, LLC to provide strategic advisory services to AVRS. Dominion has agreed to advanced costs up to an aggregate of $10,000,000. On June 28, 2017 the Company and Dominion agreed to terminate the August 20, 2015 Letter Agreement. The Company did not incur any material early termination penalties. In addition, the Company has revised the Contingent Fee Agreement with Buether Joe & Carpenter, LLC which will represent AVRS in connection with investigating and asserting claims to the AVRS patents including licensing and litigation activities. Any and all advanced costs will only become liabilities if successful. On June 6, 2017 AVRS and BJC revised the Contingent Fee Agreement as it related to the termination of the August 20, 2015 Dominion Harbor Letter Agreement. There is no guarantee that AVRS will be able to provide the capital required for the Company to continue as a going concern.

Note 2. Significant Accountin_4

Note 2. Significant Accounting Policies: Use of Estimates (Policies)	9 Months Ended
	Sep. 30, 2022
Policies
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Note 2. Significant Accountin_5

Note 2. Significant Accounting Policies: Cash and Cash Equivalents (Policies)	9 Months Ended
	Sep. 30, 2022
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents. The Company had cash at September 30, 2022 of $152, and $12,148 at December 31, 2021. No amounts resulted from cash equivalents.

Note 2. Significant Accountin_6

Note 2. Significant Accounting Policies: Going Concern (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Details
Total Stockholders' Deficit	$ (335,099)		$ (335,099)		$ (300,004)
Sales	$ 0	$ 0	0	$ 0
Proceeds from sale of common stock			$ 5,000	$ 19,000	$ 46,000

Note 2. Significant Accountin_7

Note 2. Significant Accounting Policies: Cash and Cash Equivalents (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Details
Cash and cash equivalents	$ 152	$ 12,148	$ 5,231	$ 348

Note 4. Related Party Transac_2

Note 4. Related Party Transactions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Details
Payroll	$ 162,381		$ 162,381		$ 162,380
Compensation	25	$ 25	4,071	$ 117
Advance Related Party	$ 33,493	$ 14,700	$ 33,493	$ 14,700	$ 14,700